LATEST

• REGULATORY Kumamoto Quake Hits 46 Medical Facilities; No Pharma Damage Yet: MHLW
  July 29, 2026

• BUSINESS Drug Makers, Wholesalers Rush to Gauge Kumamoto Quake Impact
  July 29, 2026

• ORGANIZATION Radiopharma Group Seeks Faster NHI Coverage for PET Imaging Agents
  July 28, 2026

• REGULATORY Japan Panel Green-Lights GSK’s Hep B Drug, Brinsupri, Hyrnuo
  July 28, 2026

• BUSINESS Pfizer Brings Eisai into Nurtec Promotion in Japan
  July 28, 2026

• BUSINESS Celltrion, Nippon Kayaku Broaden Alliance in Biopharma Biz
  July 28, 2026

• REGULATORY Japanese Women Top Life Expectancy for 41st Year Running
  July 28, 2026

• BUSINESS Ishin Eyes Domestic Production of Allostem by August 2028
  July 28, 2026

• BUSINESS Enhertu Combo Bags EU Panel Nod in 1st-Line HER2 Breast Cancer
  July 28, 2026

• BUSINESS FDA Approves Otsuka’s ADHD Drug Simtriyo
  July 28, 2026

• REGULATORY MHLW Sets FY2027 Budget Priorities for Drug Discovery, Advanced Medicine
  July 28, 2026

• BUSINESS Chugai CEO Says M&A an Option as Strategic Investment Unit Takes Shape
  July 28, 2026

• COMMENTARY Rare Cancer Case Raises New Questions about AAV Gene Therapy Safety
  July 27, 2026

• REGULATORY Japan Enacts Revised Immunization Act, Opens Way for RSV Antibodies under NIP
  July 27, 2026

• BUSINESS Chugai Forms Strategic Investment Unit to Deepen Innovation Push; Record Japan Filings Eyed
  July 27, 2026

• BUSINESS Chugai Notches Strong H1 Growth on Key Products, Roche Exports
  July 27, 2026

• BUSINESS Meiji’s Hiyasta Hits PIII Goal in Advanced Melanoma
  July 27, 2026

• ORGANIZATION Generic, Biosimilar Society Adopts 2040 Vision for Japan’s Pharma Industry
  July 27, 2026

• REGULATORY PMDA Sees Drop in Japan-China Bilateral Regulatory Exchanges
  July 27, 2026

• REGULATORY MHLW to Hear Patient Groups on OTC-Like Drug Charge Exemptions
  July 27, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »